Lv11
28 积分 2024-01-09 加入
[Design of multiple targeted drugs]
7天前
已完结
Seven glucagon-like peptide-1 receptor agonists and polyagonists for weight loss in patients with obesity or overweight: an updated systematic review and network meta-analysis of randomized controlled trials
9天前
已完结
Body weight loss and glycemic control on the outcomes of patients with NAFLD. The role of new antidiabetic agents
9天前
已完结
Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis
12天前
已完结
Current Progress and Challenges in the Development of Pharmacotherapy for Metabolic Dysfunction‐Associated Steatohepatitis
21天前
已完结
Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Nonalcoholic Fatty Liver Disease
23天前
已完结
Epidemiological Features of NAFLD From 1999 to 2018 in China
24天前
已完结
GIP-derived GIP receptor antagonists – a review of their role in GIP receptor pharmacology
26天前
已完结
Inhibition of gastric inhibitory polypeptide signaling prevents obesity
27天前
已完结
Severe asymptomatic non-alcoholic fatty liver disease in routine diabetes care; a multi-disciplinary team approach to diagnosis and management
28天前
已完结
皖公网安备34019202002308
